These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27080063)

  • 1. Variability in the effect of antidepressants upon Wfs1-deficient mice is dependent on the drugs' mechanism of actions.
    Reimets R; Raud S; Loomets M; Visnapuu T; Volke V; Reimets A; Plaas M; Vasar E
    Behav Brain Res; 2016 Jul; 308():53-63. PubMed ID: 27080063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.
    Berrocoso E; Mico JA
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1033-44. PubMed ID: 19341511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like effects in various mice strains in the tail suspension test.
    Ripoll N; David DJ; Dailly E; Hascoët M; Bourin M
    Behav Brain Res; 2003 Aug; 143(2):193-200. PubMed ID: 12900045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wfs1-deficient mice display altered function of serotonergic system and increased behavioral response to antidepressants.
    Visnapuu T; Raud S; Loomets M; Reimets R; Sütt S; Luuk H; Plaas M; Kõks S; Volke V; Alttoa A; Harro J; Vasar E
    Front Neurosci; 2013; 7():132. PubMed ID: 23914152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
    Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.
    Wilson C; Li S; Hannan AJ; Renoir T
    Neuropharmacology; 2020 May; 168():107998. PubMed ID: 32061666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
    Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
    Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
    Bourin M; Chenu F; Prica C; Hascoët M
    Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants.
    Diaz SL; Narboux-Nême N; Boutourlinsky K; Doly S; Maroteaux L
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):265-279. PubMed ID: 26727039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors.
    Dunham KE; Khaled KH; Weizman L; Venton BJ
    J Neurochem; 2024 Jun; 168(6):1097-1112. PubMed ID: 38323657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
    Sarkisyan G; Roberts AJ; Hedlund PB
    Behav Brain Res; 2010 May; 209(1):99-108. PubMed ID: 20097233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].
    Gardier A
    Therapie; 2005; 60(5):469-76. PubMed ID: 16433012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
    Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
    J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram.
    Schmidt C; Leibiger J; Fendt M
    Behav Brain Res; 2016 Jul; 308():205-10. PubMed ID: 27118715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
    Dong C; Tian Z; Fujita Y; Fujita A; Hino N; Iijima M; Hashimoto K
    Pharmacol Biochem Behav; 2022 Jan; 212():173316. PubMed ID: 34968554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
    Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
    CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.